UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - yi-tsung+lu
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Identification of a Platform to Identify Tumor-Specific T Cell Receptors (UCLA Case No. 2022-082)
SUMMARY: Researchers from UCLA’s Department of Neurosurgery and Pharmacology have developed a rapid discovery platform for the identification of tumor-specific T cell receptors to aid in more personalized and potent immunotherapy for glioblastoma. BACKGROUND: Over the past several years, immunotherapy, or therapies that enlist and strengthen...
Published: 5/20/2024
|
Inventor(s):
Robert Prins
,
Alexander Lee
,
Lu Sun
,
David Nathanson
Keywords(s):
Category(s):
Therapeutics
,
Therapeutics > CNS and Neurology
,
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Oncology > Oncology Immunotherapy
2015-172 VERY-SMALL-NUCLEAR CIRCULATING TUMOR CELL (VSNCTC) AS A DIAGNOSTIC BIOMARKER OF VISCERAL METASTASIS IN ADVANCED PROSTATE CANCER
Very-Small-Nuclear Circulating Tumor Cell (vsnCTC) as a Diagnostic Biomarker of Visceral Metastasis in Advanced Prostate CancerTech ID: 30306 / UC Case 2015-172-2SUMMARYUCLA researchers in the Department of Molecular and Medical Pharmacology have identified a novel biomarker that can be used to diagnose prostate cancer patients for the presence of visceral...
Published: 7/19/2023
|
Inventor(s):
Hsian-Rong Tseng
,
Jiaoti Huang
,
Zunfu Ke
,
Ker Chau Li
,
Min Song
,
Edwin Posadas
,
Yi-Tsung Lu
,
Jake Lichterman
,
Leland Chung
,
Jiefu Chen
Keywords(s):
Diagnostic Markers & Platforms
,
Diagnostic Platform Technologies (E.G. Microfluidics)
,
Life Science Research Tools
,
Oncology
Category(s):
Life Science Research Tools
,
Diagnostic Markers
,
Platforms > Diagnostic Platform Technologies
,
Therapeutics > Oncology